[HTML][HTML] Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment

AW Kurian, EE Hare, MA Mills… - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
Purpose Multiple-gene sequencing is entering practice, but its clinical value is unknown. We
evaluated the performance of a customized germline-DNA sequencing panel for cancer-risk …

[HTML][HTML] Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer

JD Ransohoff, V Ritter, N Purington, K Andrade… - Nature …, 2023 - nature.com
Antimicrobial exposure during curative-intent treatment of triple-negative breast cancer
(TNBC) may lead to gut microbiome dysbiosis, decreased circulating and tumor-infiltrating …

Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011

AW Kurian, DY Lichtensztajn, THM Keegan, DO Nelson… - Jama, 2014 - jamanetwork.com
Importance Bilateral mastectomy is increasingly used to treat unilateral breast cancer.
Because it may have medical and psychosocial complications, a better understanding of its …

[HTML][HTML] Use of Epic Electronic Health Record System for Health Care Research: Scoping Review

J Chishtie, N Sapiro, N Wiebe, L Rabatach… - Journal of Medical …, 2023 - jmir.org
Background Electronic health records (EHRs) enable health data exchange across
interconnected systems from varied settings. Epic is among the 5 leading EHR providers …

[HTML][HTML] Breast cancer survival defined by the ER/PR/HER2 subtypes and a surrogate classification according to tumor grade and immunohistochemical biomarkers

CA Parise, V Caggiano - Journal of cancer epidemiology, 2014 - hindawi.com
Introduction. ER, PR, and HER2 are routinely available in breast cancer specimens. The
purpose of this study is to contrast breast cancer-specific survival for the eight ER/PR/HER2 …

[HTML][HTML] Breast reconstruction following cancer treatment

B Gerber, M Marx, M Untch, A Faridi - Deutsches Ärzteblatt …, 2015 - ncbi.nlm.nih.gov
Background About 8000 breast reconstructions after mastectomy are performed in Germany
each year. It has become more difficult to advise patients because of the wide variety of …

Natural language processing approaches to detect the timeline of metastatic recurrence of breast cancer

I Banerjee, S Bozkurt, JL Caswell-Jin… - JCO clinical cancer …, 2019 - ascopubs.org
PURPOSE Electronic medical records (EMRs) and population-based cancer registries
contain information on cancer outcomes and treatment, yet rarely capture information on the …

Higher absolute lymphocyte counts predict lower mortality from early-stage triple-negative breast cancer

A Afghahi, N Purington, SS Han, M Desai… - Clinical Cancer …, 2018 - AACR
Purpose: Tumor-infiltrating lymphocytes (TIL) in pretreatment biopsies are associated with
improved survival in triple-negative breast cancer (TNBC). We investigated whether higher …

Breast cancer diagnosis, treatment, and outcomes of patients from sex and gender minority groups

E Eckhert, O Lansinger, V Ritter, M Liu, S Han… - JAMA …, 2023 - jamanetwork.com
Importance Sexual orientation and gender identity data are not collected by most hospitals
or cancer registries; thus, little is known about the quality of breast cancer treatment for …

Using natural language processing to construct a metastatic breast cancer cohort from linked cancer registry and electronic medical records data

AY Ling, AW Kurian, JL Caswell-Jin, GW Sledge Jr… - JAMIA …, 2019 - academic.oup.com
Objectives Most population-based cancer databases lack information on metastatic
recurrence. Electronic medical records (EMR) and cancer registries contain complementary …